133 related articles for article (PubMed ID: 29935954)
1. Global DNA methylation profile in medullary thyroid cancer patients.
Ceolin L; Goularte APP; Ferreira CV; Romitti M; Maia AL
Exp Mol Pathol; 2018 Aug; 105(1):110-114. PubMed ID: 29935954
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma.
Liu MJ; Liu ZF; Hou YY; Men YM; Zhang YX; Gao LY; Liu H
Oncotarget; 2017 Apr; 8(16):27520-27528. PubMed ID: 28460476
[TBL] [Abstract][Full Text] [Related]
3. Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center.
Thomas A; Mittal N; Rane SU; Bal M; Patil A; Ankathi SK; Vaish R
Head Neck Pathol; 2021 Dec; 15(4):1137-1146. PubMed ID: 33840044
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous medullary and papillary thyroid cancer: a novel entity?
Machens A; Dralle H
Ann Surg Oncol; 2012 Jan; 19(1):37-44. PubMed ID: 21626080
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of RASSF1A methylation as a putative molecular marker in papillary thyroid carcinoma.
Kunstman JW; Korah R; Healy JM; Prasad M; Carling T
Surgery; 2013 Dec; 154(6):1255-61; discussion 1261-2. PubMed ID: 24383114
[TBL] [Abstract][Full Text] [Related]
6. Thirty synchronous medullary and papillary thyroid carcinomas.
Zhang D; Yang M; Zhang X; Wang C; Li K; Wang H; Chi H; Sui C; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1153248. PubMed ID: 37065753
[TBL] [Abstract][Full Text] [Related]
7. Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior.
Biscolla RP; Ugolini C; Sculli M; Bottici V; Castagna MG; Romei C; Cosci B; Molinaro E; Faviana P; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
Thyroid; 2004 Nov; 14(11):946-52. PubMed ID: 15671773
[TBL] [Abstract][Full Text] [Related]
8. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Machens A; Dralle H
Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
[TBL] [Abstract][Full Text] [Related]
9. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
10. Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.
Ciampi R; Romei C; Pieruzzi L; Tacito A; Molinaro E; Agate L; Bottici V; Casella F; Ugolini C; Materazzi G; Basolo F; Elisei R
J Endocrinol Invest; 2017 Jan; 40(1):55-62. PubMed ID: 27535135
[TBL] [Abstract][Full Text] [Related]
11. Expression of MicroRNAs in Thyroid Carcinoma.
Zhu G; Xie L; Miller D
Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
[TBL] [Abstract][Full Text] [Related]
12. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on Clinical Behavior of Medullary Thyroid Carcinoma.
Mishra V; Kowtal P; Rane P; Sarin R
Asian Pac J Cancer Prev; 2020 May; 21(5):1289-1293. PubMed ID: 32458635
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin and obestatin in thyroid gland - immunohistochemical expression in nodular goiter, papillary and medullary cancer.
Gurgul E; Kasprzak A; Blaszczyk A; Biczysko M; Surdyk-Zasada J; Seraszek-Jaros A; Ruchala M
Folia Histochem Cytobiol; 2015; 53(1):19-25. PubMed ID: 25765090
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological analysis of 19 cases of medullary thyroid carcinoma without an increase in calcitonin.
Zhou Q; Yue S; Cheng Y; Jin J; Xu H
Exp Toxicol Pathol; 2017 Oct; 69(8):575-579. PubMed ID: 28552629
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Romei C; Ciampi R; Elisei R
Nat Rev Endocrinol; 2016 Apr; 12(4):192-202. PubMed ID: 26868437
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of RET receptor tyrosine kinase and non-coding RNAs in MTC.
Joo LJS; Zhao JT; Gild ML; Glover AR; Sidhu SB
Mol Cell Endocrinol; 2018 Jul; 469():48-53. PubMed ID: 28315378
[TBL] [Abstract][Full Text] [Related]
17. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
18. Synchronous occurrence of medullary and papillary thyroid cancer and survival rates.
Akgun E; Sager S; Beytur F; Nazari A; Ozturk T; Teksoz S; Sonmezoglu K
Indian J Cancer; 2023 Oct; 60(4):556-561. PubMed ID: 38090963
[TBL] [Abstract][Full Text] [Related]
19. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.
Suzuki A; Hirokawa M; Takada N; Higuchi M; Ito A; Yamao N; Hayashi T; Kuma S; Miyauchi A
Endocr J; 2017 Nov; 64(11):1099-1104. PubMed ID: 28883261
[TBL] [Abstract][Full Text] [Related]
20. Synchronous papillary thyroid carcinoma and medullary thyroid carcinoma - a pitfall waiting to happen.
Tang PY; Khor LY; Takano A
Malays J Pathol; 2017 Aug; 39(2):171-174. PubMed ID: 28866700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
